• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·BTAI
Held by 2 Gurus
Share

BioXcel Therapeutics, Inc. Stocks

$ 0.05Last Updated 01.10.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

$ 2.28M

In Guru Portfolios

Howard Marks

Portfolio Weight (%)

0.0%

Change

+0.02%

Fund

Oaktree Capital Management

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
Howard MarksOaktree Capital Management0.0%+0.02%
Kenneth GriffinCITADEL ADVISORS LLC0.0%+0.00%

Trending

15.10.2026 12:53

Anthropic's revenue surge will help its IPO, but is unlikely to save the entire AI sector, experts say

15.10.2026 12:37

"They Started Catching Up Late, but Quickly": Movchan's Group Guide to Investing in Kazakhstan

15.10.2026 12:21

Freedom recommended buying shares in Marriott, Hilton, and other hotel chains. What's the opportunity here?

15.10.2026 11:07

The world's leading chipmaker posted record profits for the sixth consecutive time

15.10.2026 10:26

Morning Highlights: Global Stocks Fall; Anthropic Reports Revenue Growth Ahead of Its IPO

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026